Canadian application, no grantCanada
Use of thioredoxin in the treatment of malignantly transformed cells in animals and man
CA 2065454 A1 · Owner: Rosen, Anders · Inventors: Rosen, Anders
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The use of thioredoxin in the treatment of B lymphocytic leukemia and certain other malignant diseases. The enzyme can be used either alone or in combination with co-factors such as anti-immunoglobulins, interferons or interleukin 1,2,3 or 4.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 10, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 10, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 10, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 10, 1990
GrantedNo grant recorded
Term endedSeptember 10, 2010
Patent numberCA 2065454 A1
Classification (IPC)A61K38/44 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.